---
title: "LFCR: Q2 revenue fell 6.2% to $34.2M, but new business wins and guidance reaffirmed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294961069.md"
description: "Q2 2026 revenue declined 6.2% year-over-year to $34.2M, with net loss widening to $6.2M. Despite lower sales, the company added 13 new programs, reaffirmed 2026 guidance, and completed multiple audits, supporting long-term growth and margin targets.Original document: Lifecore Biomedical, Inc. [LFCR] SEC 8-K Current Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T11:43:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294961069.md)
  - [en](https://longbridge.com/en/news/294961069.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294961069.md)
---

# LFCR: Q2 revenue fell 6.2% to $34.2M, but new business wins and guidance reaffirmed

Q2 2026 revenue declined 6.2% year-over-year to $34.2M, with net loss widening to $6.2M. Despite lower sales, the company added 13 new programs, reaffirmed 2026 guidance, and completed multiple audits, supporting long-term growth and margin targets.

Original document: Lifecore Biomedical, Inc. \[LFCR\] SEC 8-K Current Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [LFCR.US](https://longbridge.com/en/quote/LFCR.US.md)

## Related News & Research

- [LFCR: Revenue and profit declined, with liquidity sufficient but major preferred stock redemptions looming](https://longbridge.com/en/news/294961714.md)
- [Lifecore Biomedical to report fiscal Q2 results, host webcast](https://longbridge.com/en/news/294254929.md)
- [TPRO: Record H1 2026 growth driven by AI demand, with upgraded FY 2026 revenue and margin targets](https://longbridge.com/en/news/294989975.md)
- [AMPX: Q2 2026 revenue surged 126% YoY, prompting raised 2026 guidance and margin targets](https://longbridge.com/en/news/294966259.md)
- [OSS: Q2 2026 revenue jumped 62% year-over-year, but a $6.25M legal settlement drove a net loss](https://longbridge.com/en/news/294968835.md)